decreased liver function_Degs1<Gt(OST368559)Lex>/Degs1<Gt(OST368559)Lex>

http://metadb.riken.jp/0003325I129S5SvEvBrdDegs1GtOST368559LexDegs1GtOST368559LexDegs1GtOST368559Lex

decreased liver function_Degs1<Gt(OST368559)Lex>/Degs1<Gt(OST368559)Lex>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• delta(4)-desaturase, sphingolipid 1
  http://metadb.riken.jp/db/mgi_rdf/MGI:1097711

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Degs1<Gt(OST368559)Lex>/Degs1<Gt(OST368559)Lex>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Degs1<Gt(OST368559)Lex>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S5/SvEvBrd

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased liver function
  http://purl.obolibrary.org/obo/MP_0003325

文献

http://purl.org/net/cito/citesAsAuthority

• William L. Holland, et.al., Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance., Cell metabolism, 2007, 5
  http://rdf.ncbi.nlm.nih.gov/pubmed/17339025